Robin Park

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Anwaar Saeed · 2 shared papers, 2021 · strength 0.36
   • Paper GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties. DOI 10.3390/biology10070610↗
   • Paper Exceptional response to Erlotinib monotherapy in EGFR Exon 19-deleted, KRAS wild-type, Chemo-refractory advanced pancre… DOI 10.1016/j.ctarc.2021.100342↗
2. James B. Yu · 1 shared paper, 2025 · strength 0.20
   • Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
3. Jessica M. Frakes · 1 shared paper, 2025 · strength 0.20
   • Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
4. Jason W. Denbo · 1 shared paper, 2025 · strength 0.20
   • Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
5. José M. Pimiento · 1 shared paper, 2025 · strength 0.20
   • Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
6. Richard D. Kim · 1 shared paper, 2025 · strength 0.20
   • Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
7. Dae Won Kim · 1 shared paper, 2025 · strength 0.20
   • Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
8. Nicole Nardella · 1 shared paper, 2025 · strength 0.20
   • Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
9. Sarah E. Hoffe · 1 shared paper, 2025 · strength 0.20
   • Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
10. Mokenge Peter Malafa · 1 shared paper, 2025 · strength 0.20
    • Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
11. Jason B. Fleming · 1 shared paper, 2025 · strength 0.20
    • Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
12. Pamela Joy Hodul · 1 shared paper, 2025 · strength 0.20
    • Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
13. Ludimila L. Cavalcante · 1 shared paper, 2021 · strength 0.19
    • Paper GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties. DOI 10.3390/biology10070610↗
14. Andrew L. Coveler · 1 shared paper, 2021 · strength 0.19
    • Paper GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties. DOI 10.3390/biology10070610↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.